Horizon Pharma PLC (NASDAQ: HZNP) shares are trading lower by $4.73 (30 percent) at $10.85 in Monday’s session.
The catalyst for the decline is a Q1 EPS miss of $0.02 along with sales miss of $27 million. The company also lowered FY 2017 guidance for sales to $1.00-$1.04 billion from $1.24-$1.29 billion.
May 08, 2017 at 08:05PM
from Joel Elconin
No comments:
Post a Comment